Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study highlights health challenges of giant dog breeds
The Dogue de Bordeux was identified as one of the most common giant dog breeds. 

The findings raise welfare concerns about breeding for extreme size. 

Giant dog breeds in the UK live substantially shorter lives than the general dog population and experience higher levels of some disorders, according to new research.

The study by the Royal Veterinary College’s (RVC) VetCompass Programme analysed veterinary records from 2.25 million dogs that attended UK primary care practices during 2019. The team found that 8.9 years was the average lifespan of giant dogs, more than three years shorter than the average lifespan for dogs overall in England.

Their findings also reveal that three-quarters of giant dogs (73.8%) had at least one disorder recorded annually, significantly higher than the average for all dog breeds (65.8%). 

Among the most common general groups of disorders were skin disorders, musculoskeletal disease and ear disease. Ear infections, overweight or obesity and aggression were the most common specific diseases. 

Lead author Professor Dan O’Neill, professor of companion animal epidemiology at the RVC, hopes the findings will prompt wider discussion on the welfare limits of selective breeding towards extreme giantism. 

“To protect these cherished breeds and make them sustainable for the future, moving towards more moderate body sizes within these breeds may help to improve both the quality and length of life for these dogs, while still giving owners a fulfilling dog-ownership experience,” he said.

The study, published in Companion Animal Health and Genetics, identified the most common giant dog breeds in the UK as the Dogue de Bordeaux, Alaskan Malamute and Akita. 

Female giant dogs were found to live 0.8 years longer on than males (9.3 years compared to 8.5 years), suggesting that acquiring a female could give owners more time with their new dog. 

Some giant breeds in the study showed extremely short average lifespans, including Tibetan Mastiffs at just 4.8 years. Cancer was identified as the leading cause of death in giant dogs overall, while Great Danes (60.5kg), Irish Wolfhounds (64.0kg) and Saint Bernards (65.1kg) were the heaviest of the 29 giant breeds recorded.

BSAVA senior vice president, Dr Julian Hoad, said: “BSAVA welcomes this research, which adds to the growing evidence base needed to improve canine health and welfare. The veterinary profession remains concerned about the health consequences associated with extreme conformations and is committed to supporting reforms through research, education and evidence-based breeding practices.”

Image (C) BIGANDT.com/Shutterstock 

Become a member or log in to add this story to your CPD history

Update to TB Advice services

News Story 1
 Vets wishing to access TB Advice services can now use a digital contact form, following updates announced by the APHA.

This new, streamlined service allows customers to provide all necessary information upfront, minimising additional contact between the APHA and the customer. It also ensures questions are directed to the right team, significantly reducing response times.

More contact forms are expected to be announced in the coming months. For more information, visit Gov.uk  

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.